A brief talk highlighting a case of food poisoning from E. Coli 0157 given to medical students, residents, and gastroenterology fellows. This is not an exhaustive review and was meant to stimulate discussion.
20. CDC: 2012 Incidence Rate per
100,000 people
16.4214.30
E. coli
1.12
Vibrio
0.41
SalmonellaCampylobacter
21. Isolation rate of STEC O157 by age
United States 2009 (n=1,947)
National Enteric Disease Surveillance: Shiga toxin-
producing Escherichia coli (STEC) Annual Summary, 2009
25. 159 cases of E. coli O157: H7 in children
who attended a fair in Canada in 1999
BMC Public Health. 2013; 13: 799
26. Cipro- increases Shiga production in mice
models
Hemolytic Uremic Syndrome
No effect on duration of symptoms
Is concern about giving
antibiotics legitimate?
Proulx F, Turgeon JP, Delage G, et
al: Randomized, controlled trial of
antibiotic therapy for Escherichia coli
O157:H7 enteritis.
28. Micrographs of Samples from Patients with
Hemolytic–Uremic Syndrome.
Noris M, Remuzzi G. N Engl J Med 2009;361:1676-1687.
29. 1997 – 2009: 981 Cases of HUS
National Enteric Disease Surveillance: Shiga toxin-
producing Escherichia coli (STEC) Annual Summar
Median
4.5 yrs
Deaths
52 (5%)
Summer
569
(58%)
E. Coli
O157:H7
95%
30. Antibiotics and HUS
Systemic Reviews
Safdar
2002
• 9 Studies
• Neither protection nor increased risk
• Pooled OR 1.15 (95% CI 0.79-1.68)
Panos
2006
• 19 Studies
• Inconclusive
Safdar N. JAMA 2002; 288:996-1001
31. Other Treatment and HUS
Synsorb
• an agent that binds to ST to prevent
its absorption from the gut.
Antibodies
• Monoclonal Ab against Shiga 1 and 2